Literature DB >> 10448787

Pulmonary edema associated with troglitazone therapy.

I B Hirsch, J Kelly, S Cooper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448787     DOI: 10.1001/archinte.159.15.1811

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  7 in total

Review 1.  The glitazones: proceed with caution.

Authors:  D Krische
Journal:  West J Med       Date:  2000-07

Review 2.  Role of renal proximal tubule transport in thiazolidinedione-induced volume expansion.

Authors:  George Seki; Yoko Endo; Masashi Suzuki; Hideomi Yamada; Shoko Horita; Toshiro Fujita
Journal:  World J Nephrol       Date:  2012-10-06

3.  Rosiglitazone and pulmonary oedema: an acute dose-dependent effect on human endothelial cell permeability.

Authors:  I Idris; S Gray; R Donnelly
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

4.  Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.

Authors:  Hui Zhang; Aihua Zhang; Donald E Kohan; Raoul D Nelson; Frank J Gonzalez; Tianxin Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-14       Impact factor: 11.205

5.  Stimulation of ENaC activity by rosiglitazone is PPARγ-dependent and correlates with SGK1 expression increase.

Authors:  Stephane Renauld; Karine Tremblay; Siham Ait-Benichou; Maxime Simoneau-Roy; Hugo Garneau; Olivier Staub; Ahmed Chraïbi
Journal:  J Membr Biol       Date:  2010-08-26       Impact factor: 1.843

Review 6.  Combined thiazolidinedione-insulin therapy: should we be concerned about safety?

Authors:  André J Scheen
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

7.  Renal and vascular mechanisms of thiazolidinedione-induced fluid retention.

Authors:  Tianxin Yang; Sunhapas Soodvilai
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.